Stockreport

Praxis (PRAX) Surges on Positive Epilepsy Study Results [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF mid-stage study evaluating PRAX-628 in epilepsy patients with photo paroxysmal response (PPR). PRAX-628 is a next-generation, functionally selective small molecule tar [Read more]